PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder-Reference-Cited by-同舟云学术

PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder

Published:2018-06 Issue:6 Volume:28 Page:710-718
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

San Luis^ORCID,Estrada Gemma,Oudovenko Natalia,Montañés Francisco,Dobrovolskaya Natalia,Bukhanovskaya Olga,Popov Mikhail,Vieta Eduard

Funder

Ferrer Internacional

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference29 articles.

1. Alexza UK Ltd, 2013. Adasuve® 9.1 mg inhalation power. Summary of Product Characteristics. Alexza UK Ltd, Henley-on-Thames, UK.

2. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial;Allen;J. Clin. Psychiatry,2011

3. Diagnostic and Statistical Manual of Mental Disorders (5th edition): DSM-5;American Psychiatric Association,2013

4. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease;Atkinson;Health Qual. Life Outcomes,2004

5. Pharmacological management of acute agitation;Battaglia;Drugs,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds;European Journal of Medicinal Chemistry;2024-09

2. Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder;Expert Opinion on Pharmacotherapy;2023-09-04

3. Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond;Expert Review of Neurotherapeutics;2022-08-03

4. Recent advances in drug delivery to the central nervous system by inhalation;Expert Opinion on Drug Delivery;2022-05-04

5. Mood Stabilizers: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy;NeuroPsychopharmacotherapy;2022